Athena Bitcoin's Chief Compliance Officer to Speak at FIBA's 2025 AML Conference
Sam Nazzaro, Athena Bitcoin's Chief Compliance Officer to Speak at FIBA's 2025 AML Conference
MIAMI, FL / ACCESS Newswire / March 25, 2025 / Athena Bitcoin Global is proud to announce that Sam Nazzaro, Chief Compliance Officer, will be speaking on a featured panel at the FIBA 2025 Anti-Money Laundering (AML) Conference, taking place March 24-27 in Miami, Florida.
Nazzaro will participate in the panel titled 'The Changing Tide of Crypto Compliance' on March 25, 2025, where he will join other industry leaders to discuss evolving regulatory landscapes, technological innovations, and the ongoing challenges of ensuring compliance within the digital asset space.
Hosted annually by the Florida International Bankers Association (FIBA), the AML Conference brings together banking professionals, regulators, fintech leaders, and compliance experts from around the globe to share insight and best practices in anti-money laundering, counter-terrorist financing, and risk management.
'As digital assets continue to gain traction, it's critical for the industry to be proactive, transparent, and collaborative in meeting regulatory expectations,' said Nazzaro. 'I look forward to representing Athena Bitcoin and contributing to this important conversation on the future of crypto compliance.'
For more information about the conference, visit
About Athena Bitcoin Global
Athena Bitcoin Global operates an international network of Athena Bitcoin kiosks, which are free standing kiosks that permit customers to buy or sell Bitcoin in exchange for fiat currencies. The Company places its machines in convenience stores, shopping centers and other easily accessible locations in thirty-three US states and territories, and in four countries in Central and South America. Athena Bitcoin Global's comprehensive fintech platform enables POS merchant payments powered by Athena Pay and the Company provides safe, reliable and personalized trading services through its Athena Plus services. To learn more visit or follow Athena Bitcoin Global on Twitter and LinkedIn.
Statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute 'forward-looking statements' within the meaning of The Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to the expected trading commencement and closing dates. The words 'anticipate,' 'believe,' 'continue,' 'could,' 'estimate,' 'expect,' 'intend,' 'may,' 'plan,' 'potential,' 'predict,' 'project,' 'should,' 'target,' 'will,' 'would' and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: the uncertainties related to market conditions and the completion of the public offering on the anticipated terms or at all, and other factors discussed in the 'Risk Factors' section of the preliminary prospectus filed with the SEC. Any forward-looking statements contained in this press release speak only as of the date hereof, and Athena Bitcoin Global specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events, or otherwise.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
4 hours ago
- Associated Press
Solytics Partners Appoints Financial Crime Compliance Expert Sunil Kavishwar to Advisory Board to Strengthen AML Efforts in the GCC
DUBAI, AE / ACCESS Newswire / June 21, 2025 / Solytics Partners, a global leader in regulatory technology and AML/Financial Crime Compliance (FCC) solutions, is pleased to announce the appointment of Sunil Kavishwar to its Advisory Board. Sunil will support the firm's mission to drive compliance transformation and regulatory innovation across the Gulf Cooperation Council (GCC) region. Bringing over 20 years of experience in AML, sanctions compliance, and regulatory supervision, Sunil has held senior roles at the Central Bank of the UAE (CBUAE), First Abu Dhabi Bank, EY, and Accenture. He has played a leading role in shaping regional financial crime frameworks and public-private initiatives. Sunil's unparalleled experience in shaping the financial crime compliance landscape in the UAE makes him an invaluable addition to our team,' said Vikas Tyagi, CEO at Solytics Partners. 'His regulatory insights, public-private leadership, and strategic execution capabilities will be pivotal as we expand our footprint across the Middle East. ' Sunil was instrumental in establishing the UAE's first financial crime supervision framework at the CBUAE, covering institutional risk analysis, CRS/FATCA tax transparency, and virtual asset regulation. He also led the development of FATF-aligned frameworks and helped shape national policies on cross-border data sharing and sectoral risk assessments-strengthening the UAE's financial system integrity. Driving RegTech Growth in the GCC Sunil's appointment is a key milestone in Solytics Partners' strategy to accelerate the adoption of intelligent AML and sanctions solutions in the region. He will help build stronger ties with regulatory authorities and financial institutions, promoting alignment with global standards and enabling technology-driven compliance transformation. 'Solytics Partners has built a comprehensive and forward-looking FCC ecosystem,' said Sunil Kavishwar. 'I'm excited to support its mission and help institutions in the region to enhance compliance effectiveness while meeting regulatory expectations through intelligent solutions.' About Solytics Partners Solytics Partners is a global provider of RegTech solutions that streamline compliance, risk management, and regulatory reporting for financial institutions. Leveraging AI, machine learning, and advanced analytics, Solytics enables its clients to combat financial crime, improve risk oversight, and operate more efficiently. With a strong focus on the Middle East and emerging markets, Solytics Partners delivers customized, scalable solutions for AML compliance, transaction monitoring, sanctions screening, and risk assessments-helping clients stay ahead of evolving regulatory landscapes. Contact InformationDeepak Mehta Investor Relations +1-6468223440 SOURCE: Solytics Partners press release
Yahoo
a day ago
- Yahoo
LegalBison Establishes Southeast Asia Presence with New Malaysian Office
New Kuala Lumpur office strengthens LegalBison's regional reach and enhances regulatory support across Asia. Kuala Lumpur, Malaysia--(Newsfile Corp. - June 20, 2025) - LegalBison, a global regulatory advisory firm specializing in the FinTech and crypto sectors, has officially opened its new office in Kuala Lumpur, marking the company's first physical expansion into Asia and reinforcing its long-term growth strategy in emerging financial markets. LegalBison To view an enhanced version of this graphic, please visit: This milestone follows the success of LegalBison's European headquarters in Tallinn, Estonia, and represents a strategic effort to better serve clients throughout Southeast Asia-including Malaysia, Singapore, Indonesia, Thailand, and beyond. "Availability for international clients has always been one of LegalBison's key strengths," said Sabir Alijev, Chief Product Officer at LegalBison. "With our new presence in Malaysia, we now have a bird's-eye view of the local regulatory landscape and are ready to deliver timely, regionally tailored solutions." Kuala Lumpur was selected for its robust regulatory institutions, economic stability, and position as a rising hub for digital finance in Asia. Establishing operations in Malaysia allows LegalBison to deepen relationships with local partners and clients while offering more agile support in licensing, AML/KYC compliance, cross-border banking, and corporate structuring. LegalBison's move reflects the growing demand for localized compliance expertise in Asia's fast-evolving financial landscape. The Malaysian team will collaborate closely with LegalBison's Estonia office to provide seamless advisory services across time zones, ensuring clients benefit from both global perspective and local insight. By anchoring its Asia-Pacific strategy in Kuala Lumpur, LegalBison positions itself as a trusted partner to startups, growth-stage firms, and enterprises navigating complex cross-border regulatory environments. LegalBison is now actively onboarding clients across Southeast Asia and is open to strategic partnerships throughout the region and globally. For media inquiries or more information, please visit or contact pr@ About LegalBison Founded in 2020, LegalBison is a regulatory and legal advisory firm headquartered in Tallinn, Estonia. The firm supports companies in the FinTech, crypto, and high-compliance sectors with services including licensing, compliance, banking solutions, and international corporate structuring. LegalBison provides tailored, cross-border support to help businesses navigate complex regulatory environments worldwide. Media Contact LegalBison PR Teampr@ 20 4577 To view the source version of this press release, please visit
Yahoo
a day ago
- Yahoo
London Biotechnology Show 2025: Novo Nordisk harnesses AI/ML to accelerate drug development landscape
Many biotechnology companies are navigating the various obstacles prevalent within the pharmaceutical industry with the implementation of artificial intelligence (AI) and machine learning (ML) technologies to optimise and streamline processes within the drug development landscape, according to speakers from the London biotechnology conference in London, UK, on 18-19 June 2025. In recent years, the pharmaceutical industry has exhibited a significant shift into digitalisation, with AI pushing for innovation across the entire drug development value chain, from accelerating drug discovery to optimising clinical trial design to ultimately improve patient outcomes. Novo Nordisk has taken initiatives to accelerate target discovery by implementing AI/ML technologies into genetic and human-centric in vitro models. Given the significant costs associated with drug discovery and development, achieving a successful drug candidate remains a major challenge. This complex process involves different processes such as target identification and validation, lead optimisation, and lengthy clinical trials. According to one of Novo Nordisk's speakers at the London Biotechnology conference, the company aims to utilise human data input, such as genetics, samples, and multiomics from a variety of diverse patient populations, into its target discovery engine. The AI-driven engine utilises data mining and analyses linking specific diseases to novel targets to ultimately increase the number of new targets aimed to reach the first human dose. In addition, Novo Nordisk has implemented cell image foundational models driven by deep learning to increase screening throughput derived from extensive sets of genomic data. The usage of AI and deep learning tools within the virtual assay enables large image datasets of cells to be translated into text, allowing effective mapping of the various cells by their morphology, enabling researchers to gain an understanding and effectively predict the characteristics of the cells. The implementation of AI-driven technologies has the potential to streamline many aspects of the drug development value chain, from enabling standardisation of datasets across functionalities to accelerating in vitro and in silico models and tools. As a result, pharmaceutical organisations can scale their methodologies whilst simultaneously increasing output to ultimately improve patient outcomes. "London Biotechnology Show 2025: Novo Nordisk harnesses AI/ML to accelerate drug development landscape" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
